Original article
Delivering value in dermatology: Insights from skin cancer detection in routine clinical visits

Preliminary findings of this study were presented in abstract form at the International Investigative Dermatology 2013 meeting in Edinburgh, Scotland on May 8-11, 2013.
https://doi.org/10.1016/j.jaad.2014.10.030Get rights and content

Background

There are increasing demands to demonstrate and report on outcomes in dermatology. Skin cancer diagnosis through skin examination has been well studied, and is promising as a value-delivering intervention.

Objective

This study seeks to identify the rate of skin cancer diagnosis during routine visits to a large tertiary dermatology clinic.

Methods

Medical records of patients presenting for routine dermatologic care at Massachusetts General Hospital between March 28 and September 28, 2012, were retrospectively reviewed. All patients given a diagnosis of nonmelanoma skin cancer (NMSC) confirmed on biopsy specimen were identified. Billing data were used to identify the total number of patients evaluated during the study period.

Results

NMSC was diagnosed in 1266 skin biopsy specimens from 1047 (7.0%) of the 14,829 patients who presented for routine care. In all, 55% of patients with NMSC were men (mean age 70 years). Chief symptoms of patients with NMSC included general dermatologic concerns (37%), routine cancer screening (43%), and specific lesion(s) of concern (19%).

Limitations

Retrospective design and restriction to a single institution may limit the generalizability of our findings.

Conclusion

The incidence of NMSC in routine dermatology is high; these findings validate the value of care provided by dermatologists and highlight the likely increasing need for their diagnostic skills as the population ages in the United States.

Section snippets

Methods

This study was approved by the Massachusetts General Hospital Institutional Review Board. Medical records of patients presenting for routine dermatologic care between March 28 and September 28, 2012, at the Massachusetts General Hospital, a busy multiprovider urban practice setting, were retrospectively reviewed. All patients given a diagnosis of NMSC histopathologically confirmed by skin biopsy specimen were identified. Demographic information was abstracted from patient medical records, and

Results

In all, 14,829 patients (42% male, mean age 51.1 years) were evaluated for routine care among 27 medical dermatology providers. NMSC was detected in 1266 (32%) of the 4217 total skin biopsy specimens during the study period.

The incidence of NMSC was 7.1%, diagnosed in 1047 of 14,829 unique patients who presented for care. The NMSC subpopulation consisted of patients evaluated for general dermatologic issues, specific lesions of concern, and routine skin cancer screening examinations. Of the

Discussion

Skin examination is highly accurate when performed by dermatologists (sensitivity 93.3%, specificity 97.8%), mirroring the efficacy of other routinely used cancer screening modalities.7 Given that the skin cancer burden is substantial with 3.5 million cases of NMSC and 76,000 cases of melanoma expected to be discovered in 2014 and that dermatologists are in short supply, determining the best way to detect these cancers is important.4, 8

In this study a sizeable proportion of routine dermatology

References (13)

There are more references available in the full text version of this article.

Cited by (7)

  • Dermatology in the aging man

    2020, Design and Implementation of the Modern Men's Health Center: A Multidisciplinary Approach
View all citing articles on Scopus

Funding sources: None.

Conflicts of interest: None declared.

View full text